Shanghai Xuerong Bio-Technology to redeem convertible bonds early

Shanghai Xuerong Bio-Technology Co., Ltd. will proceed with the early redemption of its "Xuerong Convertible Bonds" at a price of 100.93 yuan per bond, including accrued interest. This decision follows a board meeting on September 3, 2025, which confirmed that the company's stock price had closed at or above 120% of the current conversion price (4.92 yuan/share) for at least 15 out of 30 consecutive trading days from August 14 to September 3, 2025, triggering the conditional redemption clause.

The company will cease trading of the convertible bonds on October 10, 2025, and halt conversions on October 15, 2025. The redemption registration date is October 14, 2025, with the redemption date on October 15, 2025. Funds will reach China Securities Depository and Clearing Corporation's account by October 20, 2025, and investors' accounts by October 22, 2025. After the redemption, Xuerong Convertible Bonds will be delisted from the Shenzhen Stock Exchange.

In a related development, the company's controlling shareholder, Mr. Yang Yongping, and his concerted parties experienced a passive dilution of their shareholding from 21.1404% to 20.8842% between June 30, 2025, and September 2, 2025, due to the conversion of convertible bonds. This change did not involve any active share reduction by the controlling shareholder or related parties.